12-Month Outcomes of Combined Phacoemulsification and iStent Inject in Asian Eyes with Normal Tension Glaucoma: A Single-Centre Experience
International Ophthalmology · 2022-02 · 42 (2) · 611-620
DOI: 10.1007/s10792-021-02033-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Ophthalmology, online erschienen am 15.10.2021. Verfasst von Bryan C H Ang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Tan Tock Seng Hospital, National Healthcare Group Eye Institute, Singapore, Singapore. drbryanang@gmail.com. Hauptthemen laut MEDLINE: Glaucoma, Open-Angle, Low Tension Glaucoma, Phacoemulsification. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: To evaluate efficacy and safety of the iStent inject combined with phacoemulsification in Asian eyes with normal-tension glaucoma (NTG) up to 12 months after surgery. STUDY DESIGN: Retrospective case series. METHODS: Retrospective case series of eyes undergoing surgery from April 2017 to August 2019. Outcome measures included intraocular pressure (IOP), number of topical glaucoma medications and adverse outcomes. Data were retrieved from the post-operative day 1 (POD1), week 1 (POW1), month 1 (POM1), month 3 (POM3), month 6 (POM6) and month 12 (POM12) timepoints. Data were analysed at each timepoint for eyes with available clinical data at that visit. Subgroup analysis was performed for a consistent cohort which included only eyes with data at all six follow-up timepoints. RESULTS: Data from 91 eyes in the collective subject group was analysed. Majority of subjects were male (53, 58.2%) and Chinese (79, 86.8%). Mean age was 73.2 ± 7.2 years. Pre-operatively, mean IOP was 14.3 ± 3.0 mmHg and mean number of medications was 1.5 ± 0.8. Significant IOP reduction was observed at all timepoints except POW1 and POM12. The number of medications was reduced at all timepoints (p < 0.001). By POM12, there was reduction of 1.2 ± 1.0 medications (p < 0.001). Both the collective and consistent cohorts demonstrated a trend towards decreasing surgical efficacy with time, in IOP reduction and decrease in medications. None of the eyes experienced sight-threatening complications. CONCLUSIONS: Asian eyes with NTG undergoing combined phacoemulsification and iStent inject surgery demonstrated significant and sustained reduction in number of glaucoma medications up to 12 months post-operatively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Tan Tock Seng Hospital, National Healthcare Group Eye Institute, Singapore, Singapore. drbryanang@gmail.com.
- Department of Ophthalmology, Woodlands Health Campus, National Healthcare Group Eye Institute, Singapore, Singapore. drbryanang@gmail.com.
- Department of Ophthalmology, Cardinal Santos Medical Center, Manila, Philippines.
- Department of Ophthalmology, Tan Tock Seng Hospital, National Healthcare Group Eye Institute, Singapore, Singapore.
Zitieren
APA
Ang, B. C. H., Tecson, I. C. R. O., Hu, J. Y. W., Kan, J. T. C., & Yip, L. W. L. (2022). 12-Month Outcomes of Combined Phacoemulsification and iStent Inject in Asian Eyes with Normal Tension Glaucoma: A Single-Centre Experience. International Ophthalmology, 42(2), 611-620. https://doi.org/10.1007/s10792-021-02033-3
Vancouver
Ang BCH, Tecson ICRO, Hu JYW, Kan JTC, Yip LWL. 12-Month Outcomes of Combined Phacoemulsification and iStent Inject in Asian Eyes with Normal Tension Glaucoma: A Single-Centre Experience. International Ophthalmology. 2022;42(2):611-620. doi:10.1007/s10792-021-02033-3
BibTeX
@article{Ang2022,
author = {Ang, Bryan C H and Tecson, Ivan C R O'Neill and Hu, Jeremy Y W and Kan, John T C and Yip, Leonard W L},
title = {12-Month Outcomes of Combined Phacoemulsification and iStent Inject in Asian Eyes with Normal Tension Glaucoma: A Single-Centre Experience},
journal = {International Ophthalmology},
year = {2022},
volume = {42},
number = {2},
pages = {611--620},
doi = {10.1007/s10792-021-02033-3}
}
EUVIMED